crisaborole eucrisa - PMC

Result Filters

You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 1 to 20 of 609

<< First< Prev

Page of 31

Next >Last >>

Showing results for crisaborole eucrisa. Your search for crisaborole；Eucrisa retrieved no results.

Select item 92923991.

A phase 2b, randomized, double‐blind, multicenter, vehicle‐controlled study to assess the efficacy and safety of two crisaborole regimens in Japanese patients aged 2 years and older with mild‐to‐moderate atopic dermatitis

Kayo Fujita, Michio Yagi, Shinichi Moriwaki, Mizuki Yoshida, Daniela Graham

J Dermatol. 2021 Nov; 48(11): 1640–1651. Published online 2021 Aug 26. doi: 10.1111/1346-8138.16120

PMCID:: PMC9292399

Abstract Article PDF–1.7M

Select item 100668302.

Crisaborole efficacy in murine models of skin inflammation and Staphylococcus aureus infection

Christine Youn, Dustin A. Dikeman, Evelyn Chang, Haiyun Liu, Sabrina J. Nolan, Martin P. Alphonse, Daniel P. Joyce, Qi Liu, James Meixiong, Xinzhong Dong, Lloyd S. Miller, Nathan K. Archer

Exp Dermatol. Author manuscript; available in PMC 2024 Apr 1.

Published in final edited form as: Exp Dermatol. 2023 Apr; 32(4): 425–435. Published online 2022 Dec 19. doi: 10.1111/exd.14722

PMCID:: PMC10066830

Abstract Article PDF–1.5M

Select item 101846263.

Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Study

Lawrence F. Eichenfield, Richard G. Gower, JinHua Xu, Maryam S. Alam, John C. Su, Daniela E. Myers, Paul Sanders, Bonnie Vlahos, Chuanbo Zang, Jar Lan, John Werth

Am J Clin Dermatol. 2023; 24(4): 623–635. Published online 2023 May 15. doi: 10.1007/s40257-023-00780-w

PMCID:: PMC10184626

Abstract Article PDF–1.9M

Select item 113625524.

Crisaborole combined with vitamin D demonstrates superior therapeutic efficacy over either monotherapy in mice with allergic contact dermatitis

Huachun Wang, Hetong Li, Zhengxiao Li, Xiaomei Zhao, Xiaoli Hou, Lu Chen, Lei Xing, Faming Tian

Sci Rep. 2024; 14: 20092. Published online 2024 Aug 29. doi: 10.1038/s41598-024-71135-6

PMCID:: PMC11362552

Abstract Article PDF–10M

Select item 67649315.

Efficacy and Safety of Crisaborole Ointment, 2%, for the Treatment of Mild-to-Moderate Atopic Dermatitis Across Racial and Ethnic Groups

Valerie D. Callender, Andrew F. Alexis, Linda F. Stein Gold, Mark G. Lebwohl, Amy S. Paller, Seemal R. Desai, Huaming Tan, William C. Ports, Michael A. Zielinski, Anna M. Tallman

Am J Clin Dermatol. 2019; 20(5): 711–723. Published online 2019 Jul 1. doi: 10.1007/s40257-019-00450-w

PMCID:: PMC6764931

Abstract Article PDF–1016K

Select item 104611786.

Crisaborole Inhibits Itch and Pain by Preventing Neutrophil Infiltration in a Mouse Model of Atopic Dermatitis

Darya PAVLENKO, Zeynep Todurga SEVEN, Lauren BYSTROM, Anika MARKAN, Rebecca VERPILE, Hirotake ISHIDA, Tasuku AKIYAMA

Acta Derm Venereol. 2023; 103: 13382. Published online 2023 Aug 22. doi: 10.2340/actadv.v103.13382

PMCID:: PMC10461178

Abstract Article PDF–3.1M

Select item 71250597.

Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1)

Joel Schlessinger, Julie S. Shepard, Richard Gower, John C. Su, Charles Lynde, Amy Cha, William C. Ports, Vivek Purohit, Liza Takiya, John L. Werth, Chuanbo Zang, Bonnie Vlahos, on behalf of the CARE 1 Investigators

Am J Clin Dermatol. 2020; 21(2): 275–284. Published online 2020 Mar 24. doi: 10.1007/s40257-020-00510-6

PMCID:: PMC7125059

Abstract Article PDF–1.1M

Select item 89408118.

Subgroup Analysis of Crisaborole for Mild-to-Moderate Atopic Dermatitis in Children Aged 2 to < 18 Years

Thomas A. Luger, Adelaide A. Hebert, Andrea L. Zaenglein, Jonathan I. Silverberg, Huaming Tan, William C. Ports, Michael A. Zielinski

Paediatr Drugs. 2022; 24(2): 175–183. Published online 2022 Mar 16. doi: 10.1007/s40272-021-00490-y

PMCID:: PMC8940811

Abstract Article PDF–666K

Select item 77568829.

Improvement in disease severity and pruritus outcomes with crisaborole ointment, 2%, by baseline atopic dermatitis severity in children and adolescents with mild‐to‐moderate atopic dermatitis

Lawrence F. Eichenfield, Gil Yosipovitch, Linda F. Stein Gold, Mizuho Kalabis, Chuanbo Zang, Bonnie Vlahos, Paul Sanders, Daniela E. Myers, Andrew G. Bushmakin, Joseph C. Cappelleri, Melissa Olivadoti, Amy S. Paller

Pediatr Dermatol. 2020 Nov-Dec; 37(6): 1030–1037. Published online 2020 Sep 27. doi: 10.1111/pde.14328

PMCID:: PMC7756882

Abstract Article PDF–1.3M

Select item 754042310.

Predictors of Systemic Exposure to Topical Crisaborole: A Nonlinear Regression Analysis

Vivek Purohit, Steve Riley, Huaming Tan, William C. Ports

J Clin Pharmacol. 2020 Oct; 60(10): 1344–1354. Published online 2020 May 20. doi: 10.1002/jcph.1624

PMCID:: PMC7540423

Abstract Article PDF–389K

Select item 917504511.

Evaluating the Efficacy of Crisaborole Using the Atopic Dermatitis Severity Index and Percentage of Affected Body Surface Area

Jonathan I. SILVERBERG, Anna M. TALLMAN, William C. PORTS, Robert A. GERBER, Huaming TAN, Michael A. ZIELINSKI

Acta Derm Venereol. 2020; 100(13): 5744. Published online 2020 Jun 11. doi: 10.2340/00015555-3489

PMCID:: PMC9175045

Abstract Article PDF–1.5M

Select item 993762312.

Clinical efficacy evaluation of crisaborole ointment in the treatment of vulvar leukoplakia

Lijun Li

Rev Assoc Med Bras (1992) 2023; 69(1): 97–100. Published online 2023 Feb 17. doi: 10.1590/1806-9282.20220801

PMCID:: PMC9937623

Abstract Article PDF–184K

Select item 508476113.

Crisaborole Topical Ointment, 2% in Patients Ages 2 to 17 Years with Atopic Dermatitis: A Phase 1b, Open‐Label, Maximal‐Use Systemic Exposure Study

Lee T. Zane, Leon Kircik, Robert Call, Eduardo Tschen, Zoe Diana Draelos, Sanjay Chanda, Merrie Van Syoc, Adelaide A. Hebert

Pediatr Dermatol. 2016 Jul-Aug; 33(4): 380–387. Published online 2016 May 18. doi: 10.1111/pde.12872

PMCID:: PMC5084761

Abstract Article PDF–234K

Select item 504548914.

Tolerability of Crisaborole Ointment for Application on Sensitive Skin Areas: A Randomized, Double-Blind, Vehicle-Controlled Study in Healthy Volunteers

Lee T. Zane, Matilda H. Hughes, Sepehr Shakib

Am J Clin Dermatol. 2016; 17(5): 519–526. Published online 2016 Jun 22. doi: 10.1007/s40257-016-0204-6

PMCID:: PMC5045489

Abstract Article PDF–660K

Select item 650729515.

Application of Topical Phosphodiesterase 4 Inhibitors in Mild to Moderate Atopic Dermatitis: A Systematic Review and Meta-analysis

Huan Yang, Ji Wang, Xin Zhang, Yan Zhang, Zi-li Qin, Hua Wang, Xiao-yan Luo

JAMA Dermatol. 2019 May; 155(5): 585–593. Published online 2019 Mar 27. doi: 10.1001/jamadermatol.2019.0008

Correction in:: JAMA Dermatol. 2019 Jul; 155(7): 865.

PMCID:: PMC6507295

Abstract Article

Select item 748008416.

Management of Atopic Dermatitis in Children Younger Than Two Years of Age by Community Pediatricians: A Survey and Chart Review

Anna B. Fishbein, Noor Hamideh, Jennifer Lor, Sharon Zhao, Lacey Kruse, Maryann Mason, Adolfo Ariza, Liliana Bolanos, Jonathan Necheles, Bennett Kaye

J Pediatr. Author manuscript; available in PMC 2020 Sep 9.

Published in final edited form as: J Pediatr. 2020 Jun; 221: 138–144.e3. Published online 2020 Mar 11. doi: 10.1016/j.jpeds.2020.02.015

PMCID:: PMC7480084

Abstract Article PDF–489K

Select item 621466817.

Is there still a role for conventional topical atopic dermatitis treatments in the biologic era?

K. Abuabara, C. Flohr

Br J Dermatol. Author manuscript; available in PMC 2019 Mar 1.

Published in final edited form as: Br J Dermatol. 2018 Mar; 178(3): 583–584. doi: 10.1111/bjd.16316

PMCID:: PMC6214668

Article PDF–34K

Select item 1105295618.

Maintenance of Investigator’s Static Global Assessment Response with Once-Daily Crisaborole in Participants with Mild to Moderate Atopic Dermatitis

Lawrence F. Eichenfield, Linda F. Stein Gold, Charles Lynde, Lyn Guenther, Shoshana Greenberger, Chia-Yu Chu, Zara Ghodsi, Bonnie Vlahos, Paul Sanders, Amy Cha, Juliana M. Canosa

Dermatol Ther (Heidelb) 2024 Apr; 14(4): 875–892. Published online 2024 Mar 28. doi: 10.1007/s13555-024-01129-9